Franklin Resources Inc Infinity Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.7 $28,306 - $81,560	47,977 Added 62.32%	124,968 $149,000
Q2 2022 Aug 11, 2022	SELL	$0.49 - $1.2 $17,048 - $41,750	-34,792 Reduced 31.12%	76,991 $49,000
Q4 2021 Feb 11, 2022	SELL	$1.86 - $3.36 $589 - $1,065	-317 Reduced 0.28%	111,783 $252,000
Q3 2021 Nov 12, 2021	BUY	$1.52 - $3.82 $170,392 - $428,222	112,100 New	112,100 $383,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.